Peripartum Cardiomyopathy

Great review of epidemiology, clinical presentation, and management of peripartum cardiomyopathy. Figure 3 from the article shows data from the IPAC trial  which shows that most of the events (heart transplant, death and LVAD) happened in women with intial LVEF of < 30%.